Latest Regulatory Risks News

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Brazilian Rare Earths (ASX: BRE) has delivered a striking scoping study for its Rocha da Rocha Rare Earths Province in Brazil, anchored by the Monte Alto deposit’s world-class 11.3% TREO grade, projecting robust economics and a low-cost production path.

SGH Ltd (ASX:SGH) reported a 1% rise in underlying EBIT to $1.55 billion for FY26, driven by margin gains at Boral and WesTrac, alongside a disciplined capital allocation strategy including a $500 million on-market buy-back.

News Corp’s FY26 revenue rose 7% to $9.03 billion, driven by Digital Real Estate Services and Dow Jones, while net income from continuing operations increased 15% to $743 million.

Stavely Minerals has released a comprehensive Scoping Study for its Thursday’s Gossan and Cayley Lode deposits in western Victoria, outlining a 13-year open pit copper-gold-silver operation with strong financial metrics and a 4Mtpa processing plant.

DeSoto Resources has restarted a 10,000m power auger drilling program and launched a 6,262-line kilometre airborne geophysical survey across multiple projects in Guinea’s Siguiri Basin following government approval after a pause due to illegal mining enforcement.

Block, Inc. delivered a robust Q2 2026 with 25% gross profit growth, driven by strong Cash App and Square performances, and raised its full-year guidance reflecting accelerating AI integration and hardware innovation.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Mayfield Childcare has launched a $3 million entitlement offer, fully covered by major shareholder pre-commitments and partial underwriting, to bolster working capital and support its operational turnaround amid ongoing sector challenges.

Northern Minerals propels its Browns Range Heavy Rare Earths Project forward with a planned Final Investment Decision in Q3 2026 and a significant 40% increase in the Dazzler Deposit resource.

Rua Gold’s Auld Creek Project has qualified for New Zealand’s new Fast-Track Approvals Act 2024, promising a faster permitting timeline and reduced regulatory risk as the company advances toward mine development.

Avecho Biotechnology has secured a unanimous recommendation to continue its Phase III insomnia trial without increasing sample size, alongside raising $1.9 million through option exercises and bolstering its cash position to $6.6 million.